Skip to main content
Contact Us
Subscribe
E-Edition
74°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Syros Pharmaceuticals
(NQ:
SYRS
)
5.050
-0.020 (-0.39%)
Streaming Delayed Price
Updated: 1:16 PM EDT, Apr 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Syros Pharmaceuticals
< Previous
1
2
3
4
5
6
Next >
Crude Oil Down Over 1%; Cognyte Software Shares Plummet
April 09, 2024
U.S. stocks traded lower toward the end of trading, with the S&P 500 falling around 0.4% on Tuesday. The Dow traded down 0.46% to 38,713.72 while the NASDAQ fell 0.24% to 16,215.32. The S&P 500 also...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 09, 2024
Shares of Tilray Brands, Inc. (NASDAQ: TLRY) fell sharply during Tuesday’s session after the company missed third-quarter estimates and said it no longer expects to generate positive adjusted free
Via
Benzinga
Syros Pharmaceuticals's Earnings Outlook
March 26, 2024
Via
Benzinga
Preview: Syros Pharmaceuticals's Earnings
November 13, 2023
Via
Benzinga
Earnings Outlook For Syros Pharmaceuticals
August 07, 2023
Via
Benzinga
Syros Pharmaceuticals: Q1 Earnings Insights
May 10, 2023
Via
Benzinga
Syros Pharmaceuticals's Earnings Outlook
May 09, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 09, 2024
Via
Benzinga
Top 3 Health Care Stocks You'll Regret Missing This Month
April 02, 2024
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Via
Benzinga
SYRS Stock Earnings: Syros Pharmaceuticals Misses EPS, Misses Revenue for Q4 2023
March 27, 2024
SYRS stock results show that Syros Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
Via
InvestorPlace
A Look Into Healthcare Sector Value Stocks
March 11, 2024
Via
Benzinga
Overview Of Value Stocks In The Healthcare Sector
February 12, 2024
Via
Benzinga
Syros Pharmaceuticals's Return On Capital Employed Overview
March 08, 2023
Via
Benzinga
Syros Pharmaceuticals's Earnings Outlook
March 01, 2023
Via
Benzinga
Earnings Scheduled For March 27, 2024
March 27, 2024
Companies Reporting Before The Bell • Local Bounti (NYSE:LOCL) is projected to report quarterly loss at $2.41 per share on revenue of $8.70 million.
Via
Benzinga
3 Once-in-a-Lifetime Penny Stocks With Unprecedented Surge Potential
January 31, 2024
Is your portfolio is in dire need of making new all-time highs? A new economic cycle is to send these penny stocks with potential up.
Via
InvestorPlace
5 Value Stocks To Watch In The Healthcare Sector
January 29, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 09, 2024
Via
Benzinga
5 Value Stocks To Watch In The Healthcare Sector
January 01, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
December 19, 2023
Via
Benzinga
Why Is Blood Cancer Focused Syros Pharmaceuticals Stock Soaring Today?
December 06, 2023
Syros Pharmaceuticals Inc (NASDAQ: SYRS) released initial data from its ongoing SELECT-AML-1 Phase 2 trial of tamibarotene in combination with venetoclax and azacitidine in newly diagnosed, unfit...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 06, 2023
Via
Benzinga
Small Stakes, Big Rewards: 3 Penny Stocks with 300% Upside Potential
December 03, 2023
Although even so-called penny stocks with potential carry dramatic risks, these four-baggers benefit from analyst backing.
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
October 20, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
October 02, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
August 11, 2023
Via
Benzinga
Pfizer To Terminate Development Pact With Syros Pharmaceuticals For Novel Therapies For Two Blood Disorders
July 24, 2023
Syros Pharmaceuticals Inc received notice from Pfizer Inc (NYSE: PFE), as successor to Global Blood Therapeutics Inc, exercising its right to terminate the License and Collaboration Agreement dated...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 04, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
March 31, 2023
On Friday, 93 stocks made new 52-week lows.
Via
Benzinga
Tesla To Rally Around 15%? Here Are 10 Other Analyst Forecasts For Friday
March 03, 2023
Credit Suisse cut the price target for Hormel Foods Corporation (NYSE: HRL) from $44 to $41. Credit Suisse analyst Robert Moskow maintained a Neutral rating. Hormel Foods shares fell 1.7% to $41.13 in...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.